Skip to content
Saturday 12 September 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,650.44
+0.39%
DAX
25,568.56
+0.82%
CAC 40
8,179.77
+0.78%
STOXX 50
6,325.13
+0.90%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Sponsored Ad Feature is produced by an advertiser with the specific intent to promote a product and is not produced by the Morning Wire team.
Friday 21 August 2020 9:36 am

Awareness is essential for saving lives

By:

Add as a preferred source on Google

Heart valve disease currently affects over 1.5 million people in the UK, with that number set to exceed 3 million by 2056. Despite its prevalence, awareness of the signs and symptoms is still limited.  

Heart Valve Voice is a dedicated heart valve disease charity formed by a collection of people with real experiences of heart valve disease, who aim to raise awareness of this important issue. Its ranks include a multi-disciplinary group of experts in the field (cardiologists, cardiac surgeons, GPs), cardiac patient societies and patients. 

The key symptoms of heart valve disease are breathlessness, dizziness, chest pain and fatigue. Early detection of valve disease is key to good patient outcomes, so anyone with symptoms should contact their GP for a simple stethoscope check. When a patient develops severe heart valve disease it becomes life threatening, and they are at risk of heart failure, heart attack and stroke. 

“Symptom recognition is critical to positive patient outcomes, so awareness is crucial,” says Consultant Cardiologist, Dr Dan Blackman. “We must also address inequalities in access to innovative treatments, such as TAVI, where we lag behind our European and transatlantic counterparts, if we are to achieve a best practice that delivers for every patient.” 

heartvalvevoice.com

Read more

Prothena Reports Second Quarter 2026 Financial Results and Business Highlights

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Categories

  • Life&Style

Trending Articles

  • Wetherspoon boss: ‘Not up to Burnham’ to choose who is on the high street 

  • Primark sales slip as owner dresses up retailer for demerger

  • Badger Beer maker Hall & Woodhouse doubles profit ahead of tie-up with James May

  • Crystal Palace owner Blitzer part of £1bn mega stadium redevelopment

  • Barclays faces legal scrutiny over role in £90m ‘Ponzi scheme within a Ponzi scheme’

More from Morning Wire

  • Prothena Reports Second Quarter 2026 Financial Results and Business Highlights

    Business Wire
  • Transition Bio Partners with the Little Warrior Foundation

    Business Wire
  • Alfasigma to Acquire Nordic Group B.V. Expanding Its Specialty Care Portfolio and Presence in Europe

    Business Wire
  • IMU Biosciences and Eurofins Transplant Genomics Form Strategic Partnership to Advance Transplant-Related Clinical Development Programmes

    Business Wire
  • ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer

    Business Wire
  • Prothena to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

    Business Wire
  • Silence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile

    Business Wire
  • New Drill-Free Treatment Helps Patients to Feel at Ease in the Dentist Chair

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook